Tianwen Gao Selected Research

Vitiligo

1/2021	The Formation of Melanocyte Apoptotic Bodies in Vitiligo and the Relocation of Vitiligo Autoantigens under Oxidative Stress.
1/2021	Folic Acid Protects Melanocytes from Oxidative Stress via Activation of Nrf2 and Inhibition of HMGB1.
12/2020	Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion.
1/2020	Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo.
1/2020	Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligo.
1/2020	Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress.
1/2020	Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With Vitiligo.
10/2019	Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo.
6/2019	Ablative fractional Co2 laser aided delivery of long-acting glucocorticoid in the treatment of acral vitiligo: a multicenter, prospective, self-bilateral controlled study.
4/2019	Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianwen Gao Research Topics

Disease

39	Vitiligo 01/2021 - 03/2009
26	Melanoma (Melanoma, Malignant) 01/2022 - 03/2010
16	Neoplasms (Cancer) 01/2022 - 03/2009
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 08/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2018
4	Neuroinflammatory Diseases 06/2021 - 01/2018
2	Inflammation (Inflammations) 12/2020 - 10/2019
2	Cognitive Dysfunction 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2011
2	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2011
1	Infections 10/2022
1	Encephalitis (Encephalitis, Rasmussen) 12/2020
1	Synucleinopathies 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2019

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
9	EnzymesIBA 03/2020 - 11/2010
7	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2013
6	Pharmaceutical PreparationsIBA 11/2021 - 01/2012
6	CytokinesIBA 01/2020 - 08/2007
5	ChemokinesIBA 12/2020 - 07/2015
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2007
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 11/2010
5	AntioxidantsIBA 10/2017 - 07/2012
4	AutoantigensIBA 01/2021 - 03/2011
4	Melanins (Melanin)IBA 01/2020 - 04/2010
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017 - 11/2010
3	Therapeutic UsesIBA 01/2022 - 03/2020
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	HMGB1 Protein (HMG1)IBA 01/2021 - 02/2017
3	VemurafenibIBA 12/2020 - 01/2017
3	LigandsIBA 12/2020 - 07/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2015
3	AntigensIBA 11/2016 - 07/2004
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2016 - 10/2010
3	Small Interfering RNA (siRNA)IBA 09/2011 - 07/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 01/2017
2	SolutionsIBA 06/2019 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2016
2	BilirubinIBA 01/2018 - 08/2006
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 09/2015
2	Peptide Initiation Factors (Initiation Factor)IBA 11/2017 - 07/2017
2	Granzymes (Granzyme)IBA 07/2017 - 02/2011
2	PerforinIBA 07/2017 - 02/2011
2	Monophenol Monooxygenase (Tyrosinase)IBA 11/2016 - 01/2012
2	MART-1 AntigenIBA 11/2016 - 04/2010
2	EpitopesIBA 11/2016 - 07/2004
2	Biological ProductsIBA 04/2015 - 08/2007
2	CollagenIBA 11/2013 - 05/2013
2	IgA receptor (protein B)IBA 07/2013 - 01/2012
2	Glycoproteins (Glycoprotein)IBA 07/2013 - 01/2012
2	Liposomes (Liposome)IBA 07/2011 - 09/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009 - 08/2007
1	diminazene aceturateIBA 10/2022
1	InterferonsIBA 01/2022
1	GoldIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 06/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2021
1	Long Noncoding RNAIBA 01/2021
1	Potassium Channels (Potassium Channel)IBA 01/2021
1	Poly I-CIBA 12/2020
1	Immunoglobulin M (IgM)IBA 12/2020
1	B7-H1 AntigenIBA 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	Interferon-alpha2bIBA 03/2020
1	SuspensionsIBA 01/2020
1	moesinIBA 01/2020
1	Taurochenodeoxycholic AcidIBA 01/2020
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 01/2020
1	ELAV-Like Protein 2IBA 01/2020
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2020
1	HomocysteineIBA 01/2020
1	alpha-SynucleinIBA 01/2020
1	UbiquitinIBA 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	Amino Acids FDA Link 01/2020
1	InflammasomesIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Betamethasone (Celestone)FDA Link 06/2019
1	GlucocorticoidsIBA 06/2019
1	HydrogenIBA 04/2019
1	Cytochromes c (Cytochrome c)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA 01/2019
1	Ginkgo biloba extract (Rokan)IBA 01/2019
1	honokiolIBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	Sirtuin 3IBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Capsaicin (Zostrix)FDA Link 10/2018
1	HLA-A Antigens (HLA-A)IBA 09/2018
1	Peptides (Polypeptides)IBA 09/2018
1	Deubiquitinating EnzymesIBA 01/2018

Therapy/Procedure

13	Therapeutics 01/2022 - 05/2009
5	Immunotherapy 01/2022 - 11/2016
4	Photochemotherapy (Photodynamic Therapy) 01/2016 - 03/2010
1	Aftercare (After-Treatment) 12/2020
1	Gas Lasers 06/2019